Azitra Inc Common Stock (AZTR)
Stock · AMEX · Health Care
$0.072as of 10/16/2026
Price chart
Active signals
AZTR Signal Track Record
How signals performed across all stocks →What AZTR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 22 | -11.7% | 27% | September 29, 2026 |
| Bollinger Band Breakdown | 14 | -17.5% | 14% | September 29, 2026 |
| Bollinger Band Breakout | 11 | -25.1% | 9% | August 24, 2026 |
| Any 20-session window (baseline) | -12.9% | 21% |
Computed by MarketWall from daily closing prices since April 3, 2024. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About AZTR
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epid…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 13
- Website
- azitrainc.com/
Fundamentals
- 1-day range
- $0.1157$0.1318
- Market cap
- $2.18M
- P/E (trailing)
- 6.22
- P/E (forward)
- -0.23
- EPS (trailing)
- $-2.06
- Dividend yield
- —
- Beta
- -1.03
- Avg. volume
- 1.65M
How Azitra Inc Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Feb 24, 2025 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
Azitra Inc Common Stock Competitors
Chosen by industry and closest market cap.
- AZTRAzitra Inc Common Stock$0.072▲ 0.00%Market cap $2.18MP/E 6.22$0.0518$1.09
- GNPXGenprex Inc. Common Stock$2.11▼ 7.86%Market cap $2.24MP/E —$2.53$1,210
- PPBTPurple Biotech Ltd. American Depositary Shares$1.14▼ 7.32%Market cap $2.29MP/E —$1$2.2
- SXTCChina SXT Pharmaceuticals Inc. Class A Ordinary Shares$0.065▼ 5.80%Market cap $2.06MP/E —$0.0619$83,758
- BFRGWBullfrog AI Holdings Inc. Warrants$0.13▲ 25.85%Market cap $2.04MP/E —$0.0751$0.6488
- DCOYDecoy Therapeutics Inc. Common Stock$1.17▼ 4.88%Market cap $2.40MP/E —$2.01$55.92
- OGENOragenics Inc. Common Stock$0.43▼ 2.27%Market cap $2.45MP/E 0.56$0.43$1.45
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AZTR Azitra Inc Common Stock | $2.18M | 6.22 | $0.072 | ▲ 0.00% | $0.0518$1.09 |
| GNPX Genprex Inc. Common Stock | $2.24M | — | $2.11 | ▼ 7.86% | $2.53$1,210 |
| PPBT Purple Biotech Ltd. American Depositary Shares | $2.29M | — | $1.14 | ▼ 7.32% | $1$2.2 |
| SXTC China SXT Pharmaceuticals Inc. Class A Ordinary Shares | $2.06M | — | $0.065 | ▼ 5.80% | $0.0619$83,758 |
| BFRGW Bullfrog AI Holdings Inc. Warrants | $2.04M | — | $0.13 | ▲ 25.85% | $0.0751$0.6488 |
| DCOY Decoy Therapeutics Inc. Common Stock | $2.40M | — | $1.17 | ▼ 4.88% | $2.01$55.92 |
| OGEN Oragenics Inc. Common Stock | $2.45M | 0.56 | $0.43 | ▼ 2.27% | $0.43$1.45 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 10/6/2026
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · 10/1/2026
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 9/29/2026
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · 9/29/2026
- Azitra Enters Sales Agreement With A.G.P. For Common Stock Offering; May Offer Common Stock Up To $3.50M Through A.G.P.Benzinga · 9/28/2026
- AZTR: Updated Valuation Reflects Cosmetic and EGFRi Rash ProgramsYahoo · 9/28/2026
Insider Activity
Insider Actions →- Norm Staskey · April 20, 2026 · Grant35.5K
- Francisco D. Salva · April 20, 2026 · Grant220.9K
- Travis Whitfill · April 20, 2026 · Grant64.3K
Institutional Ownership
March 31, 2026
- Total shares held
- 540.5K
- Total value held
- $126.5K
- Institutional holders
- 7
- Unknown469.9K
- Unknown30.2K
- Unknown22.5K
- Unknown15.1K
- Unknown1.7K
- Unknown1.0K
- Unknown150
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
Azitra Announces $3.5M Common Stock Sale Agreement and Updated Valuation
Azitra Inc. entered a sales agreement with A.G.P. to offer up to $3.5 million of common stock. The company also updated its valuation to reflect progress in its cosmetic and EGFRi rash programs. These developments were noted in a Benzinga report that listed Azitra among 12 healthcare stocks moving in Thursday’s after‑market session.
Azitra Announces $3.5M Common Stock Sale Agreement and Updated Valuation. Azitra Inc. entered a sales agreement with A.G.P. to offer up to $3.5 million of common stock. The company also updated its valuation to reflect progress in its cosmetic and EGFRi rash programs. These developments were noted in a Benzinga report that listed Azitra among 12 healthcare stocks moving in Thursday’s after‑market session.